Skip to main content
. 2021 Aug 24;8:704312. doi: 10.3389/fcvm.2021.704312

Table 2.

ICU course and complications of propensity score-matched cohorts.

OHCA OHCA + AMI–rCS
Variable Without CS, + AMI–rCS P + Impella, Without Impella, P
n = 90 + Impella,
n = 47
n = 15 n = 15
Bystander CPR performed 68 (75.6%) 37 (78.7%) ns 11 (73.3%) 10 (66.7%) ns
Witnessed arrest 79 (87.7%) 39 (83%) ns 14 (93.3%) 14 (93.3%) ns
ongoing CPR at admission 5 (5.6%) 6 (65.4%) ns 0 0
Out of hospital defibrillation (n) 2.9 ± 2.5 3.5 ± 2.9 ns 3.8 ± 3.8 3.7 ± 2.1 ns
Primary rhythm ns ns
  Asystole 18 (20%) 6 (12.8%) 1 (6.7%) 2 (13.3%)
  Ventricular Fibrillation 72 (80%) 41 (87.2%) 14 (93.3%) 13 (86.7%)
Time intervals
  ROSC (min) 18 (10–30) 23 (10–31) ns 20 (10–30) 25 (10–35) ns
  Duration puncture to wire crossing (min) 14.3 ± 7.1 24.3 ± 9.9 <0.001 21.5 ± 9.9 17.7 ± 5.2 ns
  Shock onset to Impella (h) 3 (1.5–4) 3 (2–4)
  Duration of Impella support (h) 89 (46–156) 90 (46–216)
Impella implantation
  Pre-PCI 28 (59.6%) 8 (53.3%)
  Post-PCI 19 (40.4%) 7 (46.7%)
LVEDP at the time of PCI 19 ± 6.3 (n = 78) 26.7 ± 6.7 <0.001 25.5 ± 4.6 25.3 ± 4.5 ns
Bridge to
  Deceased during LV support 12 (25.5%) 3 (20%)
  Recovery 34 (72.3%) 12 (80%)
  Durable VAD 1 (2.1%) 0
RRT during ICU stay 17 (18.9%) 17 (36.2%) 0.026 6 (40%) 1 (6.7%) 0.031
Hemolysis 0 16 (34%) <0.001 4 (26.7%) 0 0.032
Peripheral ischemic complications forcing vascular surgery or intervention 2 (2.2%) 4 (8.5%) ns 1 (6.7%) 1 (6.7%) ns
Good neurological outcome after 30 days (CPC ≤2) 40 (44%) 24 (51%) ns 7 (47%) 4 (27%) ns
GUSTO bleeding 0.014 0.039
  Mild 12 (13.3%) 14 (29.8%) 4 (27%) 2 (13%)
  Moderate 4 (4.4%) 5 (10.6%) 4 (27%) 0
  Severe 0 1 (2.1%) 0 0

AMI, acute myocardial infarction; CPC, cerebral performance category; CPR, cardio-pulmonary resuscitation; ICU, intensive care unit; LV, left ventricular; LVEDP, left ventricular end diastolic pressure; PCI, percutaneous coronary intervention; rCS, refractory cardiogenic shock; ROSC, return of spontaneous circulation; RRT, renal replacement therapy; VAD, ventricular assist device.